Your browser doesn't support javascript.
loading
A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC).
Theile, Susann; Johansen, Julia Sidenius; Nielsen, Dorte Lisbet; Jensen, Benny Vittrup; Hansen, Carsten Palnæs; Hasselby, Jane Preuss; Eiríksson, Sverrir Vídalín; Chen, Inna Markovna.
Afiliación
  • Theile S; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Johansen JS; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Nielsen DL; Department of Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Jensen BV; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Hansen CP; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Hasselby JP; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Eiríksson SV; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
  • Chen IM; Department of Surgery, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Pharmaceutics ; 14(3)2022 Feb 25.
Article en En | MEDLINE | ID: mdl-35335885

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca